Sac1 phosphoinositide (PI) phosphatases are important regulators of PtdIns(4)P turnover at the ER, Golgi, and plasma membrane (PM) and are involved in diverse cellular processes including cytoskeletal organization and vesicular trafficking. Here, we present evidence that Sac1 regulates axon guidance in the embryonic CNS of Drosophila. Sac1 is expressed on three longitudinal axon tracts that are defined by the cell adhesion molecule Fasciclin II (Fas II). Mutations in the sac1 gene cause ectopic midline crossing of Fas II-positive axon tracts. This phenotype is rescued by neuronal expression of wild-type Sac1 but not by a catalytically-inactive mutant. Finally, sac1 displays dosage-sensitive genetic interactions with mutations in the genes that encode the midline repellent Slit and its axonal receptor Robo. Taken together, our results suggest that Sac1-mediated regulation of PIs is critical for Slit/ Robo-dependent axon repulsion at the CNS midline.
INTRODUCTION
Phosphoinositides (PIs) are phosphorylated derivatives of the membrane lipid phosphatidylinositol (PtdIns) that play essential roles in a number of cellular processes, including actin cytoskeleton organization and intracellular membrane trafficking (Di Paolo and De Camilli, 2006) . These regulatory roles depend on their ability to recruit and/or activate various effector proteins that possess specific PI-binding domains (Lemmon, 2008) . Accumulating data suggest that each PI displays a unique subcellular distribution (Di Paolo and De Camilli, 2006) . For example, PtdIns(4)P is localized primarily to Golgi membranes, while PtdIns(3)P is concentrated in endosomal membranes. The compartment-specific distribution of PI pools is established and maintained through the precise temporal and spatial regulation of multiple PI kinases and phosphatases.
One family of PI phosphatases is characterized by the presence of a conserved Sac phosphatase domain, which is about 400 amino acids in length and contains a signature Cys-X 5 -Arg-Thr/Ser (CX 5 RT/S) catalytic motif (Hughes et al., 2000) . The
Sac-domain phosphatases in yeast and mammals can be classified into two subfamilies (Blagoveshchenskaya and Mayinger, 2009 ). The first subfamily includes yeast Sac1 and Fig4 and related mammalian proteins in which an N-terminal Sac domain is followed by a C-terminal region without any recognizable phosphatase domains. The second subfamily consists of yeast and mammalian synaptojanins, in which the N-terminal Sac phosphatase module is immediately followed by a C-terminal PI 5-phosphatase domain.
The Sac1 PI phosphatase has been shown to be an important regulator of PtdIns(4)P turnover. Biochemical analysis in yeast has demonstrated that PtdIns(4)P is the major substrate for Sac1 in vivo (Foti et al., 2001; Tahirovic et al., 2005) . A similar substrate specificity has been reported for Drosophila and mammalian Sac1 proteins (Nemoto et al., 2000; Yavari et al., 2010) . Yeast and mammalian Sac1 proteins are integral membrane proteins that localize to the endoplasmic reticulum (ER) and Golgi complex (Nemoto et al., 2000; Rohde et al., 2003; Tahirovic et al., 2005; Whitters et al., 1993) . In yeast, loss of the sac1 gene causes pleiotropic defects, such as cold sensitivity for growth (Novick et al., 1989) , inositol auxotrophy (Whitters et al., 1993) , multiple drug sensitivity (Hughes et al., 1999) , cell wall defects (Schorr et al., 2001) , and abnormal vacuole morphology (Foti et al., 2001) . In Drosophila, sac1-null mutations cause an abnormal activation of Jun kinase, which is paralleled with dorsal closure defects and embryonic lethality (Wei et al., 2003) , and Hedgehog signaling (Yavari et al., 2010) . In mice, deletion of the sac1 gene produces preimplantation lethality (Liu et al., 2008) . In mammalian cells, RNAi-mediated depletion of Sac1 causes defects in Golgi morphology and mitotic spindle organization (Liu et al., 2008) .
In this study, we show that Sac1 is highly expressed in the developing nervous system. Loss of sac1 function causes ectopic midline crossing of Fasciclin II (Fas II)-positive CNS axons, which normally do not cross the midline. We also find that the phosphatase activity of Sac1 is required in neurons for midline axon repulsion. Finally, we show that sac1 genetically interacts with slit and robo, which encode the midline repellent Slit and its receptor Robo, respectively. Thus, this study establishes a Sac1 Regulation of Midline Axon Guidance novel role for Sac1 in midline axon repulsion.
MATERIALS AND METHODS

Molecular biology
Full-length sac1 cDNA was obtained from the Drosophila Genomic Resource Center (clone ID: GH08349; USA). The entire 1,779-bp cDNA fragment was amplified by PCR and subcloned into pBluescript II KS-(pBS; Stratagene, USA). To generate pGEX-sac1-N (encoding amino acids 18-100) and pUAS-HA-sac1-WT, sac1 cDNA fragments of interest were PCR-amplified and inserted into pGEX6P1 (Amersham Pharmacia, USA) and pUAST-HA, a derivative of the pUAST vector (Brand and Perrimon, 1993) . The sac1-C388S,T395A mutation was introduced into pBS-sac1 with the QuickChange Site-Directed Mutagenesis Kit (Stratagene, USA). The following mutagenic primers were used: for sac1-C388S, 5′-GTGTCTTCCGAACG AATTCTATCGACTGTCTCGATAG-3′ and 5′-CTATCGAGAC AGTCGATAGAATTCGTTCGGAAGACAC-3′; and for sac1-T395A, 5′-CGACTGTCTCGATAGGGCGAACGTCGTGCAGA G-3′ and 5′-CTCTGCACGACGTTCGCCCTATCGAGACAGT CG-3′. The sac1-C388S,T395A insert was introduced into pUAST-HA to generate pUAS-HA-sac1-CS-TA.
Genetics
The wild-type strain used in this study was w 1118 . Two Pelement insertions in the sac1 locus (G8721 and G4263) were obtained from GenExel (Korea) and imprecisely mobilized to generate independent excision mutants, sac1 1 and sac1 2 , respectively. The EMS-induced sac1 2107 allele was kindly provided by Nicholas Harden (Simon Fraser University, Canada). UAS transgenic lines were generated in the w 1118 background using standard procedures and expressed under the control of either the ubiquitous da-GAL4 driver (Wodarz et al., 1995) or the panneuronal elav-GAL4 driver (Lin and Goodman, 1994).
Cell culture and double-stranded RNA interference Drosophila S2 cells were grown at 25°C in Schneider's medium supplemented with 10% heat-inactivated (56°C for 30 min) fetal bovine serum (FBS) and transfected in six-well plates using Cellfectin (Invitrogen, USA) according to the manufacturer's instructions.
For double-stranded RNA interference (dsRNAi) in S2 cells, DNA fragments containing coding sequences of sac1 and gfp were PCR-amplified using the following primers, which contain upstream T7 promoter sequences: sac1 sense primer, 5′-CGAATGGAGGAGATGAGTTGCTG-3′, sac1 antisense primer, 5′-CAAGTGTCTGGCGTAGCAGTCGC-3′; gfp sense primer, 5′-ACGTAAACGGCCACAAGTTC-3', gfp antisense primer, 5′-GTCCTCCTTGAAGTCGATGC-3′. The PCR products were used as DNA templates to generate dsRNAs by in vitro transcription. S2 cells were treated with dsRNA at a final concentration of 37 nM, as described previously (Lee et al., 2007) .
Antibodies and immunohistochemistry
An N-terminal region of Drosophila Sac1 (amino acids 18-100) was expressed as a GST fusion protein in Escherichia coli, purified by glutathione-Sepharose 4B column chromatography (Amersham Pharmacia, USA), and used for the immunization of rats.
Whole-mount staining of embryos was performed as previously described (Lee et al., 2000; Spencer et al., 1998) . Monoclonal antibodies against Fasciclin II (1D4) and Futsch (22C10) were purchased from the Developmental Studies Hybridoma Bank (USA) and used at a dilution of 1:5. FITC-and cyanine 3 (Cy3)-conjugated secondary antibodies (Jackson ImmunoResearch, USA) were used at 1:200.
Phosphatase activity assay
Sac1-catalyzed dephosphorylation of PtdIns(4)P was assayed in 25 μl of reaction buffer containing 200 mM sodium acetate, 100 mM Bis-Tris, 100 mM Tris-base (pH 6.0), 20 μg/ml porcine gelatin (Sigma, USA), 500 μM diC 18 -phosphatidylserine (Sigma, USA), 200 μM diC 8 -PtdIns(4)P (Echelon, USA), and 1 μg of purified recombinant GST-Sac1-WT or GST-Sac1-CS-TA. Lipid suspension in the reaction buffer was prepared as described previously (Maehama et al., 2000) . Reactions were incubated at 37°C for 1 h, stopped by adding 20 μl of 100 mM N-ethylmaleimide (NEM), and centrifuged at 14,000 × g at 4°C for 30 min. Twenty-five microliters of the resultant supernatant was transferred to a 96-well plate and incubated with 50 μl of malachite green solution for 20 min at room temperature. Phosphate release was measured by a microplate reader (MP-100, Bio-Rad) at 620 nm.
RESULTS AND DISCUSSION
Sac1 protein is expressed in the nervous system As the first step toward studying the neuronal function of Sac1, we wished to examine whether it is expressed in the developing nervous system of the embryo. We therefore generated a polyclonal antibody against an N-terminal region of Sac1 (amino acids 18-100). On western blots of Drosophila S2 cells, this antibody detected a single band of ~65 kDa, corresponding to the predicted size of Sac1 (Fig. 1A) . Levels of the 65 kDa protein were significantly decreased in cells treated with sac1 dsRNA but not in cells treated with gfp dsRNA (Fig. 1A) , suggesting the specificity of the antibody.
Immunohistochemical analysis of whole-mount wild-type embryos using anti-Sac1 revealed that the Sac1 protein is abundantly expressed during early stages of embryogenesis (e.g., stage 3) ( Fig. 1B) , suggesting a strong maternal contribution. We observed the most prominent expression in posteriorly located pole cells (Fig. 1B, asterisk) . However, at stages 13 and 16, Sac1 expression was highly restricted to the developing central nervous system (CNS) and peripheral nervous system (PNS) (Figs. 1C-1E, arrowheads and brackets, respectively). In stage 13 embryos, strong Sac1 immunoreactivity was also found in the dorsal epidermis (Fig. 1C, arrow) , consistent with its reported role in dorsal closure (Wei et al., 2003) . The immunoreactivity was substantially decreased in sac1-null (sac1 1 / sac1 2 , see below) mutant embryos at stage 16 (Fig. 1F) , confirming the specificity of anti-Sac1 signals.
The expression of Sac1 in the nervous system was further analyzed by performing double labeling with anti-Sac1 and mAb 22C10 (anti-Futsch), a marker that labels a subset of interneurons and motor neurons in the CNS as well as all sensory neurons in the PNS (Fujita et al., 1982; Hummel et al., 2000) . In the PNS of wild-type embryos at stage 16, anti-Sac1 signals perfectly overlapped with 22C10 ( Figs. 1G-1I ), revealing the strong expression of Sac1 in all sensory neurons. Like 22C10 (Hummel et al., 2000) , Sac1 was detected in the axon, cell body, and dendrite of sensory neurons. In the CNS at stage 16, anti-Sac1 signals partially overlapped with 22C10, clearly labeling a subset of longitudinal axon fascicles (Figs. 1J-1L ). The identity of these axon fascicles was investigated by double labeling with anti-Sac1 and mAb 1D4 (anti-Fasciclin [Fas] II), which labels three major longitudinal axon pathways (i.e., the medial, intermediate, and lateral Fas II pathways) in the CNS (Lin et al., 1994) as well as all motor axons in the PNS (Vactor
